Veradermics is trading 4.54% up at $110.63 as the stock attempts to recover from a sharp decline during the previous trading session.
- No company-specific announcements, earnings releases, or regulatory updates have been identified to explain the current move.
- The price action is notable despite broader sector weakness, with the XBI biotech index down 3.00% and the Nasdaq also trading lower amid risk-off pressure.